GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » Sloan Ratio %

Todos Medical (Todos Medical) Sloan Ratio % : -222.27% (As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Todos Medical Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Todos Medical's Sloan Ratio for the quarter that ended in Sep. 2022 was -222.27%.

As of Sep. 2022, Todos Medical has a Sloan Ratio of -222.27%, indicating earnings are more likely to be made up of accruals.


Todos Medical Sloan Ratio % Historical Data

The historical data trend for Todos Medical's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Todos Medical Sloan Ratio % Chart

Todos Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Sloan Ratio %
Get a 7-Day Free Trial -216.54 308.04 -11,087.91 -392.73 -181.17

Todos Medical Quarterly Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -89.98 -181.16 - -242.83 -222.27

Competitive Comparison of Todos Medical's Sloan Ratio %

For the Diagnostics & Research subindustry, Todos Medical's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Todos Medical's Sloan Ratio % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Todos Medical's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Todos Medical's Sloan Ratio % falls into.



Todos Medical Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Todos Medical's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2021 )-Cash Flow from Operations (A: Dec. 2021 )
-Cash Flow from Investing (A: Dec. 2021 ))/Total Assets (A: Dec. 2021 )
=(-43.314--11.224
--4.706)/15.115
=-181.17%

Todos Medical's Sloan Ratio for the quarter that ended in Sep. 2022 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2022 )
=(-38.768--3.797
--3.348)/14.227
=-222.27%

Todos Medical's Net Income for the trailing twelve months (TTM) ended in Sep. 2022 was -18.767 (Dec. 2021 ) + -7.588 (Mar. 2022 ) + -6.783 (Jun. 2022 ) + -5.63 (Sep. 2022 ) = $-38.77 Mil.
Todos Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2022 was -1.925 (Dec. 2021 ) + -1.263 (Mar. 2022 ) + -1.26 (Jun. 2022 ) + 0.651 (Sep. 2022 ) = $-3.80 Mil.
Todos Medical's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2022 was -1.541 (Dec. 2021 ) + -0.244 (Mar. 2022 ) + 0.241 (Jun. 2022 ) + -1.804 (Sep. 2022 ) = $-3.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Todos Medical  (OTCPK:TOMDF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2022, Todos Medical has a Sloan Ratio of -222.27%, indicating earnings are more likely to be made up of accruals.


Todos Medical Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Todos Medical's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Todos Medical (Todos Medical) Business Description

Traded in Other Exchanges
N/A
Address
121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.
Executives
Gerald Commissiong director, officer: CEO and Director 675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc 10 percent owner 875 CARRETERA 693, SUITE 201, DORADO PR 00646

Todos Medical (Todos Medical) Headlines

From GuruFocus

Todos Medical to Attend World Antiviral Congress

By Value_Insider Value_Insider 11-22-2022

Todos Medical to Present at the RHK 2022 Disruptive Growth Conference

By Value_Insider Value_Insider 12-06-2022